{
    "Trade/Device Name(s)": [
        "ELVIS HSV ID and D3 Typing Test System",
        "ELVIS HSV D and D3 Typing Test System"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K091753",
    "Predicate Device Reference 510(k) Number(s)": [
        "K971662"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GQL"
    ],
    "Summary Letter Date": "June 12, 2009",
    "Summary Letter Received Date": "June 16, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Herpes simplex virus type 1 (HSV-1)",
        "Herpes simplex virus type 2 (HSV-2)"
    ],
    "Specimen Type(s)": [
        "Cutaneous specimens",
        "Mucocutaneous specimens"
    ],
    "Specimen Container(s)": [
        "Shell-vials with or without coverslips",
        "Multi-well plates with or without coverslips"
    ],
    "Instrument(s)/Platform(s)": [
        "ELVIS HSV Cells (genetically engineered Baby Hamster Kidney cells)",
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Cell culture",
        "Qualitative identification",
        "Fluorescent antibody staining",
        "Colorimetric detection of \u03b2-galactosidase activity"
    ],
    "Methodologies": [
        "Cell-based viral culture",
        "Monoclonal antibody detection",
        "Fluorescence microscopy"
    ],
    "Submission Type(s)": [
        "System",
        "Test",
        "Reagent",
        "Medium",
        "Cell",
        "Plate",
        "Shell-vial",
        "Buffer",
        "Solution",
        "Mounting fluid"
    ],
    "Document Summary": "FDA 510(k) summary for ELVIS HSV ID and D3 Typing Test System for culture and typing of HSV-1 and HSV-2 from cutaneous and mucocutaneous specimens using cell-based culture and fluorescent antibody detection.",
    "Indications for Use Summary": "Qualitative identification and typing of HSV-1 and HSV-2 from cutaneous or mucocutaneous specimens in patients suspected of HSV infection; not established for antiviral therapy, prenatal monitoring, or CSF specimens.",
    "fda_folder": "Microbiology"
}